Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A3CRRN9
Wed, 28.05.2025
Cherry SE
Munich, 28 May 2025 – Cherry SE today announces the successful closing of the agreement announced on 8 May 2025 to transfer its CHERRY hygiene peripherals division (Active Key) to Contour Design Inc. With the closing of the transaction, the first tranche of the purchase price is being paid to Cherry SE as a cash component.
"The swift and seamless [ … ]
Wed, 14.05.2025
Cherry SE
Munich, 14 May 2025 – Cherry SE [ISIN: DE000A3CRRN9], a global manufacturer of computer input devices and digital solutions for the healthcare sector, today published its first quarter 2025 report and reaffirmed full-year guidance.
In the first quarter of 2025, Cherry SE generated Group revenue of EUR 25.3 million. Adjusted earnings before interes [ … ]
Thu, 08.05.2025
Cherry SE
Munich and Copenhagen, 8 May 2025 – German Cherry SE and Danish Contour Design have signed a contract on the strategic transition of the CHERRY hygiene peripherals business formerly known as “Active Key” following a jointly agreed process aimed at securing long-term potential and operational continuity. The transaction is expected to close at the e [ … ]
Wed, 30.04.2025
Cherry SE
Munich, 30 April 2025 – Implications of the restructuring concept on reportable elements of the 2024 annual report have led to a postponement of its publication
In the context of the audit of Cherry SE’s 2024 annual financial statements, the publication date of the annual report has been rescheduled. It was originally planned for publication on 30 [ … ]
Tue, 29.04.2025
Cherry SE
Munich, 29 April 2025 – Cherry SE announced preliminary financial performance indicators for the first quarter of 2025. Group revenue and adjusted Group EBITDA margin are in line with budget and, as planned, below the prior-year level, fully in line with the company’s expectations.
Group sales in the first quarter of 2025 amounted to EUR 25.3 mill [ … ]
Mon, 31.03.2025
Cherry SE
Munich, 31 March 2025 – With gematik’s provider approval for its SmartLink technology, CHERRY Digital Health has achieved a significant milestone in advancing digital healthcare. This solution facilitates the secure and user-friendly dispensing of e-prescriptions via the electronic health card (eGK) using NFC-enabled smartphones, ensuring seamless, [ … ]
Thu, 27.02.2025
Cherry SE
Munich, 27 February 2025 – Cherry SE announces additional preliminary group key figures, along with divisional sales and results for the last fiscal year.
As previously announced on 11 February 2025, Cherry SE concluded the 2024 financial year with a consolidated group revenue of approximately EUR 110 million and an adjusted EBITDA margin of aroun [ … ]
Mon, 17.02.2025
Cherry SE
Munich, 17 February 2025 – Charlotte Johs steps down from the Supervisory Board of Cherry SE as she intends to join the Board of a Danish Company.
Cherry SE announced today that Charlotte Johs has decided to step down from her position on the Supervisory Board of Cherry SE, effective 28 February 2025. Ms. Johs has been nominated and intends to ass [ … ]
Wed, 12.02.2025
Cherry SE
Munich, 12 February 2025 - Dr. Philip Groth will take over the position of Managing Director of Cherry Digital Health GmbH, a subsidiary of Cherry SE, on March 1, 2025.
On 1 March 2025, Dr. Groth, an experienced manager in the pharma and health tech space with a focus on leadership, business growth, governance and strategic transformation will tak [ … ]
Tue, 11.02.2025
Cherry SE
Munich, 11 February 2025 - Starting in 2025, Cherry SE will discontinue quarterly forecasts and instead prioritize a reliable full-year outlook.
Given the volatility of the capital markets and business environment, the Management Board has decided to discontinue quarterly forecasts in 2025 and instead focus on a reliable full-year outlook. This de [ … ]